Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Key eligibility criteria for Abecma:
Patients must have a referral from their oncologist to DF/BWCC's Jerome Lipper Multiple Myeloma Center to be evaluated for CAR T-cell therapy.
As a new product, there may be limited availability of Abecma. Your physician will discuss this with you and whether a clinical trial of another CAR T-cell product may be an option.
Contact Information for CAR T-Cell Therapy
For more information about CAR T-cell therapy, please call 877-801-CART (2278).